Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Tables)

6 Months Ended

Jun. 30, 2014

Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Consideration:
Amount of cash paid to Hi-Tech stockholders	$	605.0
Amount of cash paid to vested Hi-Tech option holders		40.5
Amount of cash paid to key executives under single-trigger separation payments upon change-in-control		4.1
	$	649.6
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents	$	89.7
Accounts receivable		48.5
Inventory		53.7
Other current assets		23.9
Property and equipment		45.6
Product licensing rights		343.5
IPR&D		9.4
Customer Relationships		0.3
Trademarks		5.5
Goodwill		177.1
Other non-current assets		0.6
Total assets acquired	$	797.8
Assumed current liabilities		(23.5	)
Assumed non-current liabilities		(2.8	)
Deferred tax liabilities		(121.9	)
Total liabilities assumed	$	(148.2	)
	$	649.6

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

Calculation of gain from Watson product disposition (in millions)
Consideration received	$	16.8
Intangible assets disposed		(5.9	)
Goodwill disposed		(1.1	)
Other assets disposed		(0.8	)
Pre-Tax Gain recognized	$	9.0

Calculation of gain/(loss) from ECR Divestiture (in millions)
Consideration received	$	41.0
Intangible assets divested		(33.6	)
Goodwill divested		(10.4	)
Other assets divested		(1.2	)
Assumed liabilities divested		5.1
Pre-Tax Gain recognized	$	0.9

Business Acquisition, Pro Forma Information [Table Text Block]

	Three Months Ended June 30,					Six Months Ended June 30,
	2014		2013			2014		2013
Revenue	$	157,405	$	124,558		$	306,358	$	256,493
Net income (loss)		24,597		(13,897	)		43,575		(6,167	)
Net income (loss) per diluted share	$	0.21	$	(0.14	)	$	0.37	$	(0.06	)

Betimol Acquisition [Member]

Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Betimol Acquisition:
Consideration paid in cash at closing	$	7.5
Purchase consideration payable		4.0
	$	11.5
Fair value of acquired assets:
U.S. NDA rights to Betimol®	$	11.4
Favorable supply agreement		0.1
	$	11.5

Merck Acquisition [Member]

Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Product rights:
AzaSite	$	13.8
Cosopt		21.6
Cosopt PF		20.3
Product rights total	$	55.7
Prepaid expenses		0.1
Deferred tax assets, net		0.7
Total fair value of acquired assets	$	56.5
Consideration paid	$	52.8
Gain from bargain purchase	$	3.7